SlideShare a Scribd company logo
• Intimm Meeting Abstracts
• Volume22, IssueSuppl 1 Pt 3
• Pp. iii111-iii121.
PP-061-20 Role of HLA variability in
tuberculosis
1. A. R. Villasmil,
2. M. T. Fernandez-Mestre,
3. V. Ogando and
4. Z. Layrisse
+ Author Affiliations
1. IVIC, Caracas, Bolivarian Republic of Venezuela
Abstract
Tuberculosis (TB), is still a problem of public health in Venezuela. By still unknown
reasons only 30% of the individuals exposed are infected, 5% of them develop the illness
within the first year of the infection and 95% remain in latency. The susceptibility to TB
is multifactorial and genetic factors of the host play an important role. The aim of this
study was to investigate the variability of HLA-DRB1 and HLA-DQB1 genes in patients
with clinical diagnosis of pulmonary tuberculosis and healthy individuals exposed to the
bacillus. We have examined these polymorphisms in a case-control study of 194
Venezuelan ethnically-mixed adults, including 93 patients with smear positive pulmonary
TB (mean of age 37,9 years) and 101 unrelated healthy controls (mean age 41,4 years),
selected of the Algodonal Hospital in Caracas. Definition of HLA variants was done
using Dynal RELI SSO HLA Typing Kits. Allelic and genotypic frequencies were
determined by direct count and the association was established as odd ratios (OR).
DRB1*12 and DQB1*0602 frequencies were significantly increased in patients, while
HLA- DRB1*03 and HLA-DQB1*0306 were increased in controls. The analysis of
HLA-DQB1 alleles that encode or not aspartate at position 57 at the β chain (ASP-β57)
showed the presence of the phenotypes: DQB1*0301-0302 (ASP-β57/No ASP-β57),
DQB1*0301-0307 (ASP-β57/No ASP-β57) and DQB1*0202-0501(No ASP-β57/ No
ASP-β57) only in patients. The DRB1*13-DQB1*06 haplotype was observed also
increased in the controls vs. patients (OR: 0, 26; p: 0.031). The results suggest an
influence of HLA polymorphism in the occurrence of TB in our patients.

More Related Content

What's hot

Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...
Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...
Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...
StevanSimendic79
 
Ojchd.000536
Ojchd.000536Ojchd.000536
Journal club
Journal clubJournal club
Journal club
nikitavaibhav
 
lancet
lancetlancet
frequency of cryptococcus species and varieties in méxico
frequency of cryptococcus species and varieties in méxicofrequency of cryptococcus species and varieties in méxico
frequency of cryptococcus species and varieties in méxico
IPN
 
APHRS 2019 Whom should be tested?
APHRS 2019 Whom should be tested?APHRS 2019 Whom should be tested?
APHRS 2019 Whom should be tested?
Yusuke Ebana
 
Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection
Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral RejectionIntravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection
Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection
Federal University of Bahia
 
Antigpp65
Antigpp65Antigpp65
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
spa718
 
Bank1
Bank1Bank1
Genomics and World Health - Prof. Sir David Weatherall
Genomics and World Health - Prof. Sir David WeatherallGenomics and World Health - Prof. Sir David Weatherall
Genomics and World Health - Prof. Sir David Weatherall
Human Variome Project
 
COAGULATION CONFERENCE MEXICO CITY 2013
COAGULATION CONFERENCE MEXICO CITY 2013COAGULATION CONFERENCE MEXICO CITY 2013
COAGULATION CONFERENCE MEXICO CITY 2013
Raul Alvarez dela Cadena Garnica
 
Lombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory SignatureLombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory Signature
degarden
 
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal AllocationJose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
incucai_isodp
 
Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...
Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...
Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...
Federal University of Bahia
 
Zephaniah_RERREVTC_2016
Zephaniah_RERREVTC_2016Zephaniah_RERREVTC_2016
Zephaniah_RERREVTC_2016
Zephaniah Zaiki Balogun
 
2710801
27108012710801
2710801
HardikBhatt51
 
Seminario - biologia molecular (2019)
Seminario - biologia molecular (2019)Seminario - biologia molecular (2019)
Seminario - biologia molecular (2019)
shadayvaleria
 
SEYED MOHAMMADREZA Hashemian IFI
SEYED MOHAMMADREZA Hashemian IFISEYED MOHAMMADREZA Hashemian IFI
SEYED MOHAMMADREZA Hashemian IFI
Seyed Mohammad Reza Hashemian
 
Bio da 9 (ppt)
Bio da 9 (ppt)Bio da 9 (ppt)
Bio da 9 (ppt)
JamesSabu
 

What's hot (20)

Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...
Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...
Kidney pain.org-umUMOD, Translational Nephrology! Contender for Top 10 of 201...
 
Ojchd.000536
Ojchd.000536Ojchd.000536
Ojchd.000536
 
Journal club
Journal clubJournal club
Journal club
 
lancet
lancetlancet
lancet
 
frequency of cryptococcus species and varieties in méxico
frequency of cryptococcus species and varieties in méxicofrequency of cryptococcus species and varieties in méxico
frequency of cryptococcus species and varieties in méxico
 
APHRS 2019 Whom should be tested?
APHRS 2019 Whom should be tested?APHRS 2019 Whom should be tested?
APHRS 2019 Whom should be tested?
 
Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection
Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral RejectionIntravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection
Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection
 
Antigpp65
Antigpp65Antigpp65
Antigpp65
 
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
 
Bank1
Bank1Bank1
Bank1
 
Genomics and World Health - Prof. Sir David Weatherall
Genomics and World Health - Prof. Sir David WeatherallGenomics and World Health - Prof. Sir David Weatherall
Genomics and World Health - Prof. Sir David Weatherall
 
COAGULATION CONFERENCE MEXICO CITY 2013
COAGULATION CONFERENCE MEXICO CITY 2013COAGULATION CONFERENCE MEXICO CITY 2013
COAGULATION CONFERENCE MEXICO CITY 2013
 
Lombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory SignatureLombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory Signature
 
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal AllocationJose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
 
Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...
Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...
Beneficial Effect of Plasmapheresis and IVIG on Renal Allograft Survival of P...
 
Zephaniah_RERREVTC_2016
Zephaniah_RERREVTC_2016Zephaniah_RERREVTC_2016
Zephaniah_RERREVTC_2016
 
2710801
27108012710801
2710801
 
Seminario - biologia molecular (2019)
Seminario - biologia molecular (2019)Seminario - biologia molecular (2019)
Seminario - biologia molecular (2019)
 
SEYED MOHAMMADREZA Hashemian IFI
SEYED MOHAMMADREZA Hashemian IFISEYED MOHAMMADREZA Hashemian IFI
SEYED MOHAMMADREZA Hashemian IFI
 
Bio da 9 (ppt)
Bio da 9 (ppt)Bio da 9 (ppt)
Bio da 9 (ppt)
 

Similar to Intimm Meeting Abstracts

NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
Universidad Central de Venezuela
 
Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...
Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...
Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...
UniversitasGadjahMada
 
The association between hla drb alleles with pulmonary tuberculosis in babil ...
The association between hla drb alleles with pulmonary tuberculosis in babil ...The association between hla drb alleles with pulmonary tuberculosis in babil ...
The association between hla drb alleles with pulmonary tuberculosis in babil ...
Alexander Decker
 
Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016
Global R & D Services
 
Brucellosis
BrucellosisBrucellosis
Brucellosis
Patricia Khashayar
 
My article
My articleMy article
My article
VIVEK GARG
 
BCMJ_52Vol6_tularemia
BCMJ_52Vol6_tularemiaBCMJ_52Vol6_tularemia
BCMJ_52Vol6_tularemia
Ross George Berringer
 
Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Oscar Malpartida-Tabuchi
 
2020 Trypanosoma cruzi loop-mediated isothermal.pdf
2020 Trypanosoma cruzi loop-mediated isothermal.pdf2020 Trypanosoma cruzi loop-mediated isothermal.pdf
2020 Trypanosoma cruzi loop-mediated isothermal.pdf
Jair Téllez
 
Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...
Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...
Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...
Dr. Juan Rodriguez-Tafur
 
Chagas
ChagasChagas
Chagas
mariamejia94
 
Nefropatia de celulas falciformes
Nefropatia de celulas falciformesNefropatia de celulas falciformes
Nefropatia de celulas falciformes
Cristhian Bueno Lara
 
The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...
The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...
The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...
Texas Children's Hospital
 
Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...
Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...
Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...
iosrphr_editor
 
A Study Of Clinical And Laboratory Profile Of Dengue Fever In A
A Study Of Clinical And Laboratory Profile Of Dengue Fever In AA Study Of Clinical And Laboratory Profile Of Dengue Fever In A
A Study Of Clinical And Laboratory Profile Of Dengue Fever In A
Joe Andelija
 
Reactive
ReactiveReactive
NF2 frequency of mosaicism
NF2 frequency of mosaicismNF2 frequency of mosaicism
NF2 frequency of mosaicism
Bianca Heinrich
 
bumc0028-0291
bumc0028-0291bumc0028-0291
bumc0028-0291
Anna Leigh Ursales
 
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
iosrjce
 
Artigo - Bárbara
Artigo - BárbaraArtigo - Bárbara
Artigo - Bárbara
Rodrigo Tinoco
 

Similar to Intimm Meeting Abstracts (20)

NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
 
Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...
Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...
Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson s...
 
The association between hla drb alleles with pulmonary tuberculosis in babil ...
The association between hla drb alleles with pulmonary tuberculosis in babil ...The association between hla drb alleles with pulmonary tuberculosis in babil ...
The association between hla drb alleles with pulmonary tuberculosis in babil ...
 
Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016
 
Brucellosis
BrucellosisBrucellosis
Brucellosis
 
My article
My articleMy article
My article
 
BCMJ_52Vol6_tularemia
BCMJ_52Vol6_tularemiaBCMJ_52Vol6_tularemia
BCMJ_52Vol6_tularemia
 
Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...
 
2020 Trypanosoma cruzi loop-mediated isothermal.pdf
2020 Trypanosoma cruzi loop-mediated isothermal.pdf2020 Trypanosoma cruzi loop-mediated isothermal.pdf
2020 Trypanosoma cruzi loop-mediated isothermal.pdf
 
Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...
Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...
Cytokines and T-Lymphocyte count in patients in the acute and chronic phases ...
 
Chagas
ChagasChagas
Chagas
 
Nefropatia de celulas falciformes
Nefropatia de celulas falciformesNefropatia de celulas falciformes
Nefropatia de celulas falciformes
 
The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...
The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...
The Significance of Bacterial and Fungal Coinfection in the Setting of Viral ...
 
Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...
Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...
Clinico-haematological Profile of Falciparum Malaria in a Rural Hospital of T...
 
A Study Of Clinical And Laboratory Profile Of Dengue Fever In A
A Study Of Clinical And Laboratory Profile Of Dengue Fever In AA Study Of Clinical And Laboratory Profile Of Dengue Fever In A
A Study Of Clinical And Laboratory Profile Of Dengue Fever In A
 
Reactive
ReactiveReactive
Reactive
 
NF2 frequency of mosaicism
NF2 frequency of mosaicismNF2 frequency of mosaicism
NF2 frequency of mosaicism
 
bumc0028-0291
bumc0028-0291bumc0028-0291
bumc0028-0291
 
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
 
Artigo - Bárbara
Artigo - BárbaraArtigo - Bárbara
Artigo - Bárbara
 

More from Universidad Central de Venezuela

Variabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonar
Variabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonarVariabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonar
Variabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonar
Universidad Central de Venezuela
 
Polimorfismo 308 y TB
Polimorfismo 308 y TBPolimorfismo 308 y TB
Polimorfismo 308 y TB
Universidad Central de Venezuela
 
ganador_cartel
ganador_cartelganador_cartel
EL GENOTIPO
EL GENOTIPOEL GENOTIPO
Biomédica 2011;31sup.3209-421
Biomédica 2011;31sup.3209-421Biomédica 2011;31sup.3209-421
Biomédica 2011;31sup.3209-421
Universidad Central de Venezuela
 
Expresión inmunohistoquímica de la proteína p170 en cancer de mama
Expresión inmunohistoquímica de la proteína p170 en cancer de mamaExpresión inmunohistoquímica de la proteína p170 en cancer de mama
Expresión inmunohistoquímica de la proteína p170 en cancer de mama
Universidad Central de Venezuela
 

More from Universidad Central de Venezuela (7)

Variabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonar
Variabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonarVariabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonar
Variabilidad del gen IL-10 y susceptibilidad a la tuberculosis pulmonar
 
Polimorfismo 308 y TB
Polimorfismo 308 y TBPolimorfismo 308 y TB
Polimorfismo 308 y TB
 
ganador_cartel
ganador_cartelganador_cartel
ganador_cartel
 
Evaluacion inmunologica de peptidos sinteticos003
Evaluacion inmunologica de peptidos sinteticos003Evaluacion inmunologica de peptidos sinteticos003
Evaluacion inmunologica de peptidos sinteticos003
 
EL GENOTIPO
EL GENOTIPOEL GENOTIPO
EL GENOTIPO
 
Biomédica 2011;31sup.3209-421
Biomédica 2011;31sup.3209-421Biomédica 2011;31sup.3209-421
Biomédica 2011;31sup.3209-421
 
Expresión inmunohistoquímica de la proteína p170 en cancer de mama
Expresión inmunohistoquímica de la proteína p170 en cancer de mamaExpresión inmunohistoquímica de la proteína p170 en cancer de mama
Expresión inmunohistoquímica de la proteína p170 en cancer de mama
 

Intimm Meeting Abstracts

  • 1. • Intimm Meeting Abstracts • Volume22, IssueSuppl 1 Pt 3 • Pp. iii111-iii121. PP-061-20 Role of HLA variability in tuberculosis 1. A. R. Villasmil, 2. M. T. Fernandez-Mestre, 3. V. Ogando and 4. Z. Layrisse + Author Affiliations 1. IVIC, Caracas, Bolivarian Republic of Venezuela Abstract Tuberculosis (TB), is still a problem of public health in Venezuela. By still unknown reasons only 30% of the individuals exposed are infected, 5% of them develop the illness within the first year of the infection and 95% remain in latency. The susceptibility to TB is multifactorial and genetic factors of the host play an important role. The aim of this study was to investigate the variability of HLA-DRB1 and HLA-DQB1 genes in patients with clinical diagnosis of pulmonary tuberculosis and healthy individuals exposed to the bacillus. We have examined these polymorphisms in a case-control study of 194 Venezuelan ethnically-mixed adults, including 93 patients with smear positive pulmonary TB (mean of age 37,9 years) and 101 unrelated healthy controls (mean age 41,4 years), selected of the Algodonal Hospital in Caracas. Definition of HLA variants was done using Dynal RELI SSO HLA Typing Kits. Allelic and genotypic frequencies were determined by direct count and the association was established as odd ratios (OR). DRB1*12 and DQB1*0602 frequencies were significantly increased in patients, while HLA- DRB1*03 and HLA-DQB1*0306 were increased in controls. The analysis of HLA-DQB1 alleles that encode or not aspartate at position 57 at the β chain (ASP-β57) showed the presence of the phenotypes: DQB1*0301-0302 (ASP-β57/No ASP-β57), DQB1*0301-0307 (ASP-β57/No ASP-β57) and DQB1*0202-0501(No ASP-β57/ No ASP-β57) only in patients. The DRB1*13-DQB1*06 haplotype was observed also increased in the controls vs. patients (OR: 0, 26; p: 0.031). The results suggest an influence of HLA polymorphism in the occurrence of TB in our patients.